Delivering health education, medicines, supplies and volunteers where needed.

Home | Contact Us | Donor Login

Join us on: Facebook Twitter YouTube Flickr Follow HOPE on Pinterest

Stay Updated

Sign up to receive important emails from us on current issues.

Please leave this field empty
FacebookLinkedInTwitter
Share on Facebook
Cancel
Share on Twitter
A short URL will be added to the end of your Tweet.

Cancel
Share on LinkedIn
Cancel
| Print

Richard T. Clark, Executive Chairman, Project HOPE

Richard T. Clark, Chairman of Merck & Co. Inc., New Chairman of Project HOPE Board

Richard T. Clark became Chairman of the Project HOPE Board of Directors in October 2011. He began serving as the Executive Chairman for Project HOPE on March 31, 2015, during the interim search for Project HOPE’s new CEO and President following the retirement of John P. Howe, III, M.D.

Mr. Clark is the retired chairman of Merck & Company, serving in this role from April 2007 until December 2011. In a career spanning 39 years with Merck, Mr. Clark also held a broad range of senior management positions within the company’s manufacturing division.

From 2008 to 2009 Mr. Clark served as board chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the country's leading pharmaceutical research and biotechnology companies. He is also Chairman of Washington & Jefferson College Board of Trustees and the Catholic Foundation of Greater Philadelphia. Mr. Clark is a member of the Board of Trustees of PENN Medicine and Chairman of its Cardiovascular Institute Leadership Council. PENN Medicine is an enterprise consisting of the University of Pennsylvania School of Medicine and the University of Pennsylvania Health System and is dedicated to medical education, biomedical research and excellence in patient care. Mr. Clark also serves on Automatic Data Processing, Inc.’s (ADP) Board of Directors, and Corning’s Board of Directors.

Mr. Clark earned a bachelor’s degree in Liberal Arts from Washington & Jefferson College and an MBA from American University. He served as a lieutenant in the U.S. Army from 1970 to 1972 before joining Merck.

Board of Directors

Officers

Richard T. Clark ~  Chairman
Retired Chairman
Merck & Co., Inc.

George B. Abercrombie ~ Vice Chairman
Retired President & CEO
Hoffmann-LaRoche

William F. Brandt, Jr. ~ Treasurer
Retired Chairman & CEO
American Woodmark

Dayton Ogden ~ Secretary
Former Chairman
SpencerStuart Worldwide

Directors

John P. Casey
Executive Vice President, Marine Systems
General Dynamics

Deborah DiSanzo
Former CEO
Philips Healthcare

John D. Fowler
Vice Chairman
Wells Fargo Securities

Jack M. Gill Ph.D.
President
The Gill Foundation

Bernard A. Harris, Jr., M.D.
President & CEO
Vesalius Ventures, Inc.

Dennis J. Manning
Retired Chairman & CEO
Guardian Life

Gerhard N. Mayr
Chairman
UCB

J. Michael McQuade, Ph.D.
Senior Vice President
Science & Technology
United Technology Corporation

Viren Mehta, PharmaD
Founder and Managing Partner, Mehta Partners
Co-founder and Chairman, Gather Health

Walter G. Montgomery
Partner & CEO
RLM Finsbury

Reynold W. Mooney
Principal, Global Leader, Life Sciences & Health Care Practice
Deloitte Touche Tohmatsu Limited

Steven B. Pfeiffer, Esq.
Former Chair of the Executive Committee
Fulbright & Jaworski LLP
Partner, Norton Rose Fulbright

Michael Rosenblatt, M.D.
Executive Vice President and Chief Medical Officer
Merck & Co., Inc.

Stephen H. Rusckowski
President and CEO 
Quest Diagnostics

Charles A. Sanders, M.D. ~ Chairman Emeritus
Retired Chairman & CEO
GlaxoSmithKline

Ambassador Miriam E. Sapiro
Visiting Fellow, Brookings

Curt M. Selquist
Operating Partner
Water Street Healthcare Partners

Marshall Smith
Co-Head of the Consumer Retail Healthcare Group
Goldman Sachs & Company

Louis W. Sullivan, M.D.
President Emeritus
Morehouse School of Medicine

Henri A. Termeer 
Retired Chairman, President & CEO
Genzyme Corporation

Christian Weinrank
Vice President & Managing Director, Germany
Medtronic Germany

Karen Welke
Retired Group Vice President
3M Company

Peter Wilden, Ph.D.
Chief Financial Officer
Ferring Pharmaceuticals

Bradley A. J. Wilson
Chairman
PharmaKodex Ltd.

Emeritus Members

John W. Galiardo
Maurice R. Greenberg
William L. Henry
Ben L. Holmes
Robert A. Ingram
Edward J. Ludwig
James E. Preston
Jerry E. Robertson, Ph.D.